Compare ACADIA Pharmaceuticals Inc. (ACAD) vs Google Inc (GOOG) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ACADIA Pharmaceuticals Inc. vs Google Inc — how do they compare? ACADIA Pharmaceuticals Inc. trades at $25.99 (market cap $4.49B), while Google Inc trades at $357.85 (market cap $4.46T). The key difference: Google Inc is far larger — about 993.3× ACADIA Pharmaceuticals Inc.'s market cap, and Google Inc pays a 0.24% dividend while ACADIA Pharmaceuticals Inc. pays none. Which is the better fit depends on your goals.
| ACAD | GOOG | |
|---|---|---|
Market Cap | $4.49B | $4.46T |
Sector | Health | Technology |
52-Week High | $28.06 | $399.06 |
52-Week Low | $20.06 | $175.16 |
Enterprise Value | $3.69B | $4.42T |
Volume | — | 1,511,127 |
Dividend Yield | — | 0.24% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ACADIA Pharmaceuticals Inc.
Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.
Read more on ACAD →About Google Inc
Alphabet Inc. operates as a holding company. The Company, through its subsidiaries, provides web-based search, advertisements, maps, software applications, mobile operating systems, consumer content, enterprise solutions, commerce, and hardware products.
Read more on GOOG →
